Theme Translational Metabolism
Target audience Researchers and clinicians
Language English

General

On April 4th, the next Dutch Translational Metabolism Conference (DTMC) seminar of the year 2024 will take place, with keynote speaker Romain Barrès, Director of Research at the Institute of Molecular and Cellular Pharmacology (IPMC) CNRS/Université Côte d'Azur, France and Professor at the center for Basic Metabolic Research (CBMR) at the University of Copenhagen, Denmark. He will be joined by Ricky Siebeler from the Amsterdam UMC.

Professor Romain Barrès (Université Côte d'Azur)

Romain Barrès is Director of Research at the Institute of Molecular and Cellular Pharmacology (IPMC) CNRS/Université Côte d’Azur in France and Professor at the Center for Basic Metabolic Research (CBMR), University of Copenhagen, Denmark. He obtained his Bachelor in Physiology from the University of Toulouse III (France), a Master and PhD in Molecular Biology from the University of Nice Côte d’Azur, France, and conducted his postdoctoral studies at the Karolinska Institutet in Stockholm.

Epigenetic rewiring of skeletal muscle after exercise training

He worked as a Lecturer at the University of New South Wales in Sydney before he returned to establish his group at the CBMR in 2010. Prof. Barrès is currently Head of the Gametic Epigenetic Consortium against Obesity (GECKO).

His research is focused on the understanding of lifestyle influences on the predisposition to develop metabolic diseases later in life. His group notably developed expertise in the field of epigenetic inheritance and led seminal work addressing the effect of preconceptional factors on the epigenome of spermatozoa and the metabolic phenotype of the offspring

Ricky Siebeler (Amsterdam UMC)

Ricky Siebeler is a PhD student specializing in the epigenetic regulation of macrophages in the context of atherosclerosis. Currently, he works under the guidance of Prof. Menno de Winther and Dr. Marten Hoeksema at the Amsterdam UMC. His primary focus lies in characterizing novel epigenetic regulators of interferon signaling in macrophages, with the overarching goal of understanding how these regulators can be targeted to mitigate inflammatory responses in atherosclerosis.

The histone demethylase KDM3A modulates the pro-inflammatory phenotype of macrophages in atherosclerosis

Ricky obtained his Bachelor's and Master's degrees in Nutrition and Health, specializing in Molecular Nutrition and Toxicology at Wageningen University & Research. For his first master internship he worked on a project at the Department of Nutrition, Metabolism, and Genomics in Wageningen, focusing on the role of mitochondrial fatty acid synthesis in macrophage activation. Subsequently, his second internship at the Department of Medicine, Leiden, focused on lipid metabolism and chronobiology in atherosclerosis. Combining interests from both disciplines, Ricky’s is excited to build upon his prior experiences in his current research.

Date and Location

Time From 16:00 to 17:15
Start date Thursday, April 4, 2024
Location Online
The seminar will take place on Zoom, Join Zoom Meeting, ID: 977 5878 7358, Password: 434282.

Costs and registration

None

Contact

You can find more information about DTMC on their website.

If you have any suggestion for speakers, questions, or if you would like to be added to our mailing list, please don’t hesitate to ask: info@translationalmetabolism.nl